why choose us

First received: November 29, 2022

Clinical Trial: A Study for Observing Severe Asthma in Patients Treated With Tezepelumab

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Asthma

Study Type: OBSERVATIONAL


Official Title: Asthma Control in Severe Asthma Patients Treated With Tezepelumab: A Prospective, Observational, Real-World Evidence Study (ASCENT)

Brief Summary: A study involving primary data collection within real-world settings of participants who initiate treatment with tezepelumab for severe uncontrolled asthma.This study will complement evidence obtained from randomized controlled trials and provide new data focusing on the holistic and patient reported outcome (PRO).

Read more